![](/img/cover-not-exists.png)
Assessing the cardio–cerebrovascular safety of vildagliptin: meta-analysis of adjudicated events from a large Phase III type 2 diabetes population
A. Schweizer, S. Dejager, J. E. Foley, A. Couturier, M. Ligueros-Saylan, W. KothnyVolume:
12
Year:
2010
Language:
english
Pages:
10
DOI:
10.1111/j.1463-1326.2010.01215.x
File:
PDF, 522 KB
english, 2010